These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 34234380

  • 1. RANKL expression in chondrocytes and its promotion by lymphotoxin-α in the course of cartilage destruction during rheumatoid arthritis.
    Takeshita A, Nishida K, Yoshida A, Nasu Y, Nakahara R, Kaneda D, Ohashi H, Ozaki T.
    PLoS One; 2021; 16(7):e0254268. PubMed ID: 34234380
    [Abstract] [Full Text] [Related]

  • 2. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis.
    Martínez-Calatrava MJ, Prieto-Potín I, Roman-Blas JA, Tardio L, Largo R, Herrero-Beaumont G.
    Arthritis Res Ther; 2012 Jun 18; 14(3):R149. PubMed ID: 22709525
    [Abstract] [Full Text] [Related]

  • 3. The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
    Komuro H, Olee T, Kühn K, Quach J, Brinson DC, Shikhman A, Valbracht J, Creighton-Achermann L, Lotz M.
    Arthritis Rheum; 2001 Dec 18; 44(12):2768-76. PubMed ID: 11762937
    [Abstract] [Full Text] [Related]

  • 4. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ, Suzuki E, Stanecki C, Shin HS, Qui H, Adamopoulos IE.
    J Autoimmun; 2012 Dec 18; 39(4):369-76. PubMed ID: 22867712
    [Abstract] [Full Text] [Related]

  • 5. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
    Tsushima H, Okazaki K, Ishihara K, Ushijima T, Iwamoto Y.
    Arthritis Res Ther; 2015 Feb 17; 17(1):31. PubMed ID: 25811130
    [Abstract] [Full Text] [Related]

  • 6. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim HR, Kim KW, Jung HG, Yoon KS, Oh HJ, Cho ML, Lee SH.
    Arthritis Res Ther; 2011 Mar 14; 13(2):R43. PubMed ID: 21401926
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Kim KW, Kim HR, Park JY, Park JS, Oh HJ, Woo YJ, Park MK, Cho ML, Lee SH.
    Arthritis Rheum; 2012 Apr 14; 64(4):1015-23. PubMed ID: 22034096
    [Abstract] [Full Text] [Related]

  • 8. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
    Shen Y, Jiang T, Wang R, He S, Guo M, Zuo J, He D.
    BMC Complement Altern Med; 2015 Mar 24; 15():77. PubMed ID: 25887296
    [Abstract] [Full Text] [Related]

  • 9. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB.
    Arthritis Rheum; 2004 Dec 24; 50(12):3831-43. PubMed ID: 15593184
    [Abstract] [Full Text] [Related]

  • 10. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate.
    Revu S, Neregård P, af Klint E, Korotkova M, Catrina AI.
    Arthritis Res Ther; 2013 Dec 24; 15(6):R205. PubMed ID: 24295447
    [Abstract] [Full Text] [Related]

  • 11. miR-145-5p Increases Osteoclast Numbers In Vitro and Aggravates Bone Erosion in Collagen-Induced Arthritis by Targeting Osteoprotegerin.
    Chen Y, Wang X, Yang M, Ruan W, Wei W, Gu D, Wang J, Guo X, Guo L, Yuan Y.
    Med Sci Monit; 2018 Jul 30; 24():5292-5300. PubMed ID: 30059491
    [Abstract] [Full Text] [Related]

  • 12. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients.
    Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N.
    Arthritis Rheum; 2001 May 30; 44(5):1003-12. PubMed ID: 11352231
    [Abstract] [Full Text] [Related]

  • 13. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.
    Skoumal M, Kolarz G, Haberhauer G, Woloszczuk W, Hawa G, Klingler A.
    Rheumatol Int; 2005 Nov 30; 26(1):63-9. PubMed ID: 15889303
    [Abstract] [Full Text] [Related]

  • 14. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.
    Arthritis Rheum; 2000 Feb 30; 43(2):259-69. PubMed ID: 10693864
    [Abstract] [Full Text] [Related]

  • 15. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
    Nakano K, Okada Y, Saito K, Tanaka Y.
    Arthritis Rheum; 2004 Aug 30; 50(8):2450-8. PubMed ID: 15334457
    [Abstract] [Full Text] [Related]

  • 16. DJ-1 controls T cell differentiation and osteoclastogenesis in rheumatoid arthritis.
    Min HK, Kim SH, Lee JY, Lee SH, Kim HR.
    Sci Rep; 2022 Jul 27; 12(1):12767. PubMed ID: 35896699
    [Abstract] [Full Text] [Related]

  • 17. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis.
    Lee KA, Kim KW, Kim BM, Won JY, Min HK, Lee DW, Kim HR, Lee SH.
    Arthritis Res Ther; 2019 Dec 12; 21(1):283. PubMed ID: 31831038
    [Abstract] [Full Text] [Related]

  • 18. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis.
    Cui MY, Li X, Lei YM, Xia LP, Lu J, Shen H.
    Eur Cytokine Netw; 2019 Jun 01; 30(2):67-73. PubMed ID: 31486401
    [Abstract] [Full Text] [Related]

  • 19. In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells.
    Byron CR, Barger AM, Stewart AA, Pondenis HC, Fan TM.
    Am J Vet Res; 2010 Jun 01; 71(6):615-22. PubMed ID: 20513175
    [Abstract] [Full Text] [Related]

  • 20. Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis.
    Kim JY, Lee EY, Lee EB, Lee YJ, Yoo HJ, Choi J, Song YW.
    Arthritis Res Ther; 2012 Aug 17; 14(4):R187. PubMed ID: 22901757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.